OKYO Pharma Ltd — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| CERRONE GABRIELE M | Executive Chairman | Other | 499,468 | $1.50 | $749,202 | 9,107,832 | Oct 27, 2023 |
| BRANCACCIO JOHN P | — | Purchase | 16,670 | $1.50 | $25,005 | 16,670 | Sep 15, 2023 |
| CERRONE GABRIELE M | Non-Executive Chairman | Purchase | 37,500 | $4.00 | $150,000 | 62,500 | May 19, 2022 |
| JACOB GARY S | Chief Executive Officer | Purchase | 12,500 | $4.00 | $50,000 | 12,500 | May 19, 2022 |
| CERRONE GABRIELE M | Executive Chairman | Purchase | 5,800,000 | $0.08 | $464,000 | 548,981,215 | May 19, 2022 |
| CERRONE GABRIELE M | Non-Executive Chairman | Purchase | 1,625,000 | $0.06 | $97,500 | 544,806,215 | May 17, 2022 |
| CERRONE GABRIELE M | Non-Executive Chairman | Purchase | 25,000 | $3.87 | $96,750 | 25,000 | May 17, 2022 |